Independent prognostic value of MRI beyond existing methods of determining cardiovascular risk – is there a role?

Abstract

Imaging is a highly attractive option for improved risk stratification, as it allows direct detection and quantification of subclinical and clinical disease burden. Among available imaging techniques, MRI may be particularly suited for comprehensive cardiovascular risk assessment given its non-ionizing nature and high soft-tissue contrast. In this editorial, the authors review the emerging evidence in different clinical scenarios, indicating the incremental role of MRI for determining risk for future cardiovascular events.

Keywords::

• cardiac MRI
• prognosis
• prognostic value
• risk stratification

Financial & competing interests disclosure

J Hausleiter has received a research grant from Siemens and Speakers bureau for Abbott Vascular. F Bamberg has received Speaker's bureau for Siemens Healthcare, Bayer Healthcare and holds an unrestricted research grant from Bayer Healthcare. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.